Compare RDY & DCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDY | DCI |
|---|---|---|
| Founded | 1984 | 1915 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Pollution Control Equipment |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 9.5B |
| IPO Year | 2001 | 2005 |
| Metric | RDY | DCI |
|---|---|---|
| Price | $15.32 | $88.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $16.90 | ★ $99.00 |
| AVG Volume (30 Days) | ★ 1.9M | 882.9K |
| Earning Date | 05-12-2026 | 06-02-2026 |
| Dividend Yield | 0.52% | ★ 1.38% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.75 |
| Revenue | N/A | ★ $2,844,900,000.00 |
| Revenue This Year | $7.72 | $4.58 |
| Revenue Next Year | $3.50 | $5.18 |
| P/E Ratio | ★ $18.67 | $32.39 |
| Revenue Growth | N/A | ★ 4.05 |
| 52 Week Low | $12.19 | $68.96 |
| 52 Week High | $15.27 | $112.84 |
| Indicator | RDY | DCI |
|---|---|---|
| Relative Strength Index (RSI) | 78.69 | 58.40 |
| Support Level | $13.80 | $86.31 |
| Resistance Level | N/A | $88.43 |
| Average True Range (ATR) | 0.29 | 2.05 |
| MACD | 0.23 | 0.40 |
| Stochastic Oscillator | 85.91 | 73.77 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Donaldson is a leading manufacturer of filtration systems and replacement parts, including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors. The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.7 billion in revenue in its fiscal 2025.